Agilent Selects SeqWright as First Target Enrichment Certified Service Provider for AB SOLiD Sequencing
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Agilent Technologies Inc. and SeqWright DNA Technology Services have announced that SeqWright is the first Certified Service Provider (CSP) for the Agilent SureSelect Target Enrichment System for use with the next-generation AB SOLiD sequencing platform.
According to Agilent, SureSelect, a research-use-only system, has been shown to increase the speed and cost-efficiency of next generation sequencing by enabling researchers to focus experiments on genomic regions of interest rather than sequencing the entire genome. The system offers optimized protocols for the Illumina Genome Analyzer and Life Technologies’ AB SOLiD platforms.
“When leading genomics companies like SeqWright add SureSelect to their extensive portfolios of services, it illustrates the momentum this technology has gained in just the year and a half since its introduction,” said Fred P. Ernani, Ph.D., Agilent SureSelect platform business manager. “We are very pleased to see SeqWright gain the status of the first CSP for SureSelect on the SOLiD platform.”
According to Agilent, SureSelect, a research-use-only system, has been shown to increase the speed and cost-efficiency of next generation sequencing by enabling researchers to focus experiments on genomic regions of interest rather than sequencing the entire genome. The system offers optimized protocols for the Illumina Genome Analyzer and Life Technologies’ AB SOLiD platforms.
“When leading genomics companies like SeqWright add SureSelect to their extensive portfolios of services, it illustrates the momentum this technology has gained in just the year and a half since its introduction,” said Fred P. Ernani, Ph.D., Agilent SureSelect platform business manager. “We are very pleased to see SeqWright gain the status of the first CSP for SureSelect on the SOLiD platform.”
